United States: Patent

Subscribe

Intellectual property law and copyright law thought leadership, articles, podcasts, videos and webinars from expert sources across the legal world. Explore insights covering topics such as licensing and syndication, patent law, trade secrets and trademark law.

USPTO Director Squires Signals Future Update To AI Patent Eligibility Guidance At 2025 AIPLA Annual Meeting

At the 2025 American Intellectual Property Law Associate (AIPLA) Annual Meeting, John Squires, Director of the United State Patent and Trademark Office (USPTO), delivered a keynote speech that may prove pivotal...

United States IP

KG

K&L Gates LLP

New Continuation Fee Among 2025 USPTO Changes Impacting Biotech

The U.S. Patent and Trademark Office (USPTO) has implemented a Continuation Application Fee (CAF) for certain continuing applications filed more than six or nine years after their earliest benefit date.

United States IP

PL

Polsinelli LLP

Proposed Rulemaking Aims To Change Access To IPR Proceedings

On October 17, 2025, the USPTO issued a notice of proposed rulemaking ("Notice") regarding the rules of practice for inter partes review before the PTAB.

United States IP

JD

Jones Day

New USPTO IDS Fees Raise Strategic Stakes For Biotech Filings

Effective Jan. 19, 2025, the USPTO implemented a new fee framework for IDS submissions, charging up to $800 for applications that list more than 200 references.

United States IP

PL

Polsinelli LLP

Register Today: Webinar Series: How The BPCIA Is Reshaping Biologics And Biosimilar Patenting Strategies

United States IP

GP

Goodwin Procter LLP

Defining Claim Terms By Implication: Lexicography Lessons From Aortic Innovations LLC v. Edwards Lifesciences Corporation

United States IP

CM

Crowell & Moring LLP

Revvo v. Cerebrum Sensor: In Precedential Decision, Director Vacates Institution Because Petitioner Adopted Patent Owner's District Court Claim Constructions Without Sufficient Explanation

United States IP

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Big Trouble In Small Entity: The USPTO's New Crackdown On Fee Status Fraud

United States IP

SS

Seyfarth Shaw LLP

When Section 101 Goes To Trial: Alice Step Two Decided By Jury

United States IP

HK

Holland & Knight

Platform & Marketplace Responsibility For Unlawful/Infringing Content And Safe Harbors

United States IP

WL

World Law Group

Thinking Globally: International Patent Filing And Inventors' Rights

United States IP

LA

Lando & Anastasi

Navigating The New Landscape Of AI Patent Protection

United States Technology

BB

Baker Botts LLP

AI Transparency Data Disclosures: Preparing For California AB 2013

United States Technology

WG

Weil, Gotshal & Manges LLP

UPC vs EPO: Key Procedural Differences In Challenges To Patent Validity

United States IP

JA

J A Kemp LLP

District Court Invalidates Patents For Bridge Cheating Detection Software Under § 101

United States IP

JM

Jeffer Mangels Butler & Mitchell LLP

Resolving Construction Conflicts Efficiently: A Guided Mediation Approach

United States Litigation

J

JAMS

From Conflict To Clarity: Why The ADR Experience Matters In Successful Resolution

United States Litigation

J

JAMS

Importing Steel Into Mexico A Pillar Of Compliance For Suppliers Trading With Mexico

United States International

BG

Braumiller Law Group, PLLC

Tariffs, Contracts And The Negotiation Imperative: Why The Old Playbook Won't Work

United States International

J

JAMS

Duty Of Disclosure Considerations For Medical Device Patent Applicants With Parallel FDA Submissions

Bringing a new medical device to market is a complex dance that often involves navigating both patent law and regulatory approval.

United States IP

MG

Marshall, Gerstein & Borun LLP

Additional Nelson Mullins Alerts

On October 16, 2025, the United States Patent and Trademark Office (USPTO) issued a proposed rulemaking notice regarding significant changes to the procedures for instituting inter partes review (IPR) proceedings.

United States IP

NM

Nelson Mullins Riley & Scarborough LLP

Patent Law Alert -- Proposed Changes To USPTO's Inter Partes Review Process – Does It Start A New "Race To Judgment" On Patent Invalidity?

On October 17, 2025, the U.S. Patent and Trademark Office (USPTO) issued a Public Notice proposing significant changes to the rules...

United States IP

CL

Cowan Liebowitz & Latman PC

Federal Circuit Confirms That PTAB Patentability Findings Do Not Have Issue-Preclusive Effect In District Court

The Federal Circuit recently vacated a summary judgment ruling of invalidity, holding that the district court erred in applying preclusive effect to the Patent Trial and Appeal Board's unpatentability findings...

United States IP

AG

Akin Gump Strauss Hauer & Feld LLP

JONES DAY TALKS®: Protecting The Crown Jewels: IP Due Diligence In Venture Capital Financings

United States IP

JD

Jones Day

The Patent Eligibility Restoration Act: Revisions To Section 101 Moving Closer To The Finish Line

United States IP

UT

Upadhye Tang

UPC Penalty Payments Are Only Payable If Court Has Previously Ordered Forfeiture Of Sum For Non-compliance

United States IP

AO

A&O Shearman

USPTO And Other Resources Offer IP And Business Assistance To Veterans And Military Personnel

United States IP

K

Klemchuk

Untimely Disclosure Leads To Loss Of Defense

United States IP

BT

Barnes & Thornburg LLP

The Patent Eligibility Restoration Act (PERA) Could Provide A Much Needed Boost To Key Technology Sectors Of The U.S. Economy

United States IP

HR

Heslin Rothenberg Farley & Mesiti

United States Patent And Trademark Office Announces Pre-Examination Patent Application Search Pilot

United States IP

LA

Lando & Anastasi

USPTO Reaffirms Patent Eligibility For AI Innovations

United States IP

LA

Lando & Anastasi

USPTO Offers Path To Faster Patent Examination Through New Pilot Program

United States IP

LA

Lando & Anastasi

Oddity Of Examination Of Certain Corporate Witnesses In The U.S. v. Germany

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

United States Patent And Trademark Office Announces Pre-Examination Patent Application Search Pilot

On October 8, 2025, the United States Patent and Trademark Office (USPTO) announced the launch of its Artificial Intelligence Search Automated Pilot (ASAP!) Program.

United States IP

LA

Lando & Anastasi

USPTO Reaffirms Patent Eligibility For AI Innovations

In Ex parte Desjardins (Google's DeepMind Technologies), the USPTO's Appeals Review Panel (ARP) vacated a §101 rejection of claims directed to a machine-learning training method...

United States IP

LA

Lando & Anastasi

USPTO Offers Path To Faster Patent Examination Through New Pilot Program

On October 24, 2025 the United States Patent and Trademark Office (USPTO) announced the launch of a new pilot program that will afford patent Applicants...

United States IP

LA

Lando & Anastasi

Oddity Of Examination Of Certain Corporate Witnesses In The U.S. v. Germany

In cross-border patent litigation, corporate testimony plays a critical role—but how it is handled varies dramatically between jurisdictions.

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

The New Director Institution Process: USPTO Hour Webinar Provides Updates And First Decision Is Released

United States IP

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Pending, Unexamined Utility Applications Have A Short-Lived Opportunity To Jump The Line

In an effort to evaluate the impact of a limited claim set on pendency and examination quality, the USPTO launched the Streamlined Claim Set Pilot Program on October 27, 2025.

United States IP

OB

Osha Bergman Watanabe & Burton LLP

USPTO Proposes Dramatic Restrictions For Inter Partes Review Institution

On October 17, 2025, the United States Patent and Trademark Office (USPTO) published a notice of proposed rulemaking (NPRM) that, if accepted, would dramatically change the criteria...

United States IP

OB

Osha Bergman Watanabe & Burton LLP

The Federal Circuit Will Not Disrupt The USPTO's New Era Of Discretionary Denials

In a trio of rulings on Nov. 6, 2025, the Federal Circuit delivered a clear message: discretionary denial of Inter Partes Review (IPR) petitions is unreviewable on appeal.

United States IP

B

BakerHostetler

When Taking Both Sides Backfires: The USPTO Director's Surprising Intervention In The Smart Tire Sensor Wars

In the high-stakes world of patent litigation, accused infringers often pursue parallel strategies in district court and at the Patent Trial and Appeal Board ("PTAB").

United States IP

YMF Law Tokyo

FRAND Quarterly: Navigating The Global SEP Landscape – November 2025

Worldwide Anti-trust

W

WilmerHale

Trending At The PTAB: A Potential Barrier To Serial Challenges

United States IP

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

EPO Referral May Shift Patent Description Amendment Rules

United States IP

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Can You Keep A Secret? The Trade Secret Tightrope In FDA-Regulated MedTech

United States IP

M

Mintz

Not All Expirations [Re] Secured Settled Expectations For Petitioner

United States IP

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Potential Changes To Enforcement Under The Bayh-Dole Act

United States IP

SH

Stites & Harbison PLLC

Federal Circuit Denies Challenges To USPTO Director's Discretionary Denial Decisions

United States IP

PL

Polsinelli LLP

The Regulatory Compliance Defense For "Improper" Orange Book Listings

United States IP

W

WilmerHale

Texas Jury Clears AT&T In Cellular Suit From Atlantic IP's Daingean Technologies

United States IP

RC

RPX Corporation

Discretionary Decision Statistics Update

United States IP

JD

Jones Day

Federal Circuit Reaffirms 'By Another' Standard Under Pre-AIA Law In Patent Dispute Over Merck Serono's MS Drug Highlights

United States IP

BT

Barnes & Thornburg LLP

Secondary Considerations In Patent Validity Challenges: Understanding Their Role In IPR And District Court Litigation

United States IP

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Sip, Sip, Hooray? An Analysis Of Florida's SIP Proposal To Curb High Pharmaceutical Prices

United States Healthcare

PD

Phelps Dunbar LLP

Continuation In-Part Imparts Standing In Patent Assignment Appeal

United States IP

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

USPTO Launches Streamlined Claim Set Pilot To Accelerate Patent Examination

United States IP

PL

Polsinelli LLP

See more

Highlighted Content

Parallel Imports, A Global Phenomenon, And A Very Grey Area Regarding International Trade

United States International

BG

Braumiller Law Group, PLLC

Knowing What's Ahead: Dispute Resolution Planning For Startups In The New Age Of Generative AI

United States Litigation

J

JAMS

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Latest Videos

See more

Update On Plausibility – A Review Of Case Law In Europe Following G2/21 (Video)

JA

J A Kemp LLP

Fair University License Terms: Due Diligence & Negotiation Tips For Startups (Video)

C

Crowley Law LLC

Tips For Small Brands To Consider When Protecting Their Intellectual Property (Video)

WL

Withers LLP

How To Navigate IP Issues In Robotics (Video)

FH

Foley Hoag LLP

2024 PTAB Year In Review: New Procedures And Potential Changes Impact AIA Trial Strategies (Video)

BK

Brooks Kushman

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More